Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-Time Glucose Monitoring Using FreeStyle Libre 3 in Adults With Type 2 Diabetes On Basal Insulin Plus SGLT2 Inhibitor and/or GLP-1

NCT05944432 is registered in ClinicalTrials.gov with Abbott Diabetes Care as lead sponsor.

NCT NCT05944432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05944432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-Time Glucose Monitoring Using FreeStyle Libre 3 in Adults With Type 2 Diabetes On Basal Insulin Plus SGLT2 Inhibitor and/or GLP-1
Lead sponsor
Abbott Diabetes Care
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 26, 2023
Completion date
November 30, 2027
Enrollment
469 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2